“Efficacy of Secukinumab in Patients With Mild to Moderate Psoriasis: A Pooled Analysis of 6 Phase 3 Studies ” (2023) SKIN The Journal of Cutaneous Medicine, 7(6), p. s231. doi:10.25251/skin.7.supp.231.